Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia

NCT: NCT05460611 · RECRUITING

NCT IDNCT05460611
StatusRECRUITING
Start Date2023-12-07
Completion2028-07
SponsorMontefiore Medical Center (OTHER)
First posted
Last updated

Brief Summary

Single-center, open-label, baseline-controlled, pilot study evaluating the use of a Nonablative 1470 nm laser for the treatment of androgenetic alopecia and scarring alopecia.

Frequently Asked Questions

What is 1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia?

1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia is a clinical trial registered under NCT05460611. Current status: RECRUITING.

What is the status of NCT05460611?

The current status of NCT05460611 (1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia) is: RECRUITING.

When did 1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia start?

1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia started on 2023-12-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑